GE HealthCare Technologies Inc.’s Stock Price Skyrockets to $93.48, Marking an Impressive +8.82% Uptick

GE HealthCare Technologies Inc. (GEHC)

93.48 USD +7.58 (+8.82%) Volume: 7.4M

GE HealthCare Technologies Inc.’s stock price sees a robust performance at 93.48 USD, enjoying a significant surge of +8.82% this trading session with a high trading volume of 7.4M, and showcasing a remarkable YTD percentage increase of +19.57%, highlighting the stock’s strong market presence and growth potential.

Latest developments on GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. has seen a surge in its stock price today following the release of its Q4 earnings report and 2025 profit forecast. The company reported earnings in line with estimates and a profit increase that beat expectations, driven by steady demand for its medical devices. GE HealthCare’s business growth was boosted by its imaging and diagnostic drug units, leading to a 9% jump in its stock price. Analysts have given a strong buy recommendation for the company, citing promising financial performance and growth prospects. With a positive outlook for the future, GE HealthCare is poised for continued success in the healthcare technology sector.

A look at GE HealthCare Technologies Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

GE HealthCare Technologies Inc. provides a wide range of medical technology, pharmaceutical diagnostics, and digital solutions. With a Smartkarma Smart Score of 4 for Momentum, the company is showing strong positive momentum in the market. This indicates that GE HealthCare Technologies is likely to continue to see growth and success in the future.

While GE HealthCare Technologies has solid scores in Value and Growth, with scores of 3 for both factors, it may face challenges in terms of Dividend and Resilience, with scores of 2 for each. This suggests that the company may need to focus on improving its dividend payouts and building resilience in the face of market fluctuations. Overall, GE HealthCare Technologies has a positive outlook for the future, with potential for continued growth and success in the medical technology industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma